Showing 19,021 - 19,040 results of 44,251 for search '(( 5 ((nn decrease) OR (mean decrease)) ) OR ( 50 ((ng decrease) OR (a decrease)) ))', query time: 1.49s Refine Results
  1. 19021
  2. 19022
  3. 19023
  4. 19024
  5. 19025

    Supplementary Material for: Efficacy of Omalizumab in Mastocytosis: Allusive Indication Obtained from a Prospective, Double-Blind, Multicenter Study (XOLMA Study) by Distler M. (8332950)

    Published 2020
    “…<b><i>Results:</i></b> Sixteen patients were analyzed: 7 to omalizumab and 9 to placebo (mean age 47.7 ± 13.8 vs. 45.4 ± 8.8 years; 66.6 vs. 85.7% were female; mean disease duration 10.0 ± 5.1 vs. 4.5 ± 2.9 years, respectively). …”
  6. 19026
  7. 19027
  8. 19028

    Table_1_Using Electrical Impedance Myography as a Biomarker of Muscle Deconditioning in Rats Exposed to Micro- and Partial-Gravity Analogs.DOCX by Carson Semple (7450427)

    Published 2020
    “…Indeed, one EIM measure (i.e., phase-slope) that was previously reported as highly sensitive, was significantly decreased after HLS (day 0: 14.60 ± 0.97, day 7: 11.03 ± 0.81, and day 14: 10.13 ± 0.55 | Deg/MHz|, p < 0.0001), and was associated with a significant decrease in muscle grip force. …”
  9. 19029

    Association between High Serum Homocysteine Levels and Biochemical Characteristics in Women with Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis by Yuming Meng (2826575)

    Published 2016
    “…Standardized mean difference (SMD) and the corresponding 95% confidence intervals (95% CIs) were used as a measure of effect size.</p><p>Results</p><p>A total of 34 studies (with 1,718 cases and 1,399 controls) of homocysteine levels in PCOS were pooled in this meta-analysis. …”
  10. 19030
  11. 19031
  12. 19032
  13. 19033

    Table_1_A Cost-Effectiveness and Quality of Life Analysis of Different Approaches to the Management and Treatment of Localized Prostate Cancer.DOCX by Aleksandra Harat (813785)

    Published 2020
    “…Microsimulations of radical prostatectomy, 3D-conformal radiotherapy, or active monitoring were performed using Medicare reimbursement schedules and clinical trial results for a target population of men aged 50–69 years with newly diagnosed localized prostate cancer (T1-T2, NX, M0) over a time horizon of 10 years. …”
  14. 19034

    Table_1_Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia.DOCX by Prajwal Boddu (5780843)

    Published 2018
    “…Three and one complete responses were observed at dose-levels “0” and “1,” respectively; the overall response rate (ORR) was 36% (4 of 11 patients). A50% decrease in CXCR4 mean fluorescence intensity was observed in 4 of 9 patients by flow cytometry, indicating incomplete suppression of CXCR4-receptor occupancy.…”
  15. 19035

    Table_1_Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia.DOCX by Prajwal Boddu (5780843)

    Published 2018
    “…Three and one complete responses were observed at dose-levels “0” and “1,” respectively; the overall response rate (ORR) was 36% (4 of 11 patients). A50% decrease in CXCR4 mean fluorescence intensity was observed in 4 of 9 patients by flow cytometry, indicating incomplete suppression of CXCR4-receptor occupancy.…”
  16. 19036

    An experimental study on the effect of using gas-to-liquid (GTL) fuel on diesel engine performance and emissions by Bassiony, M. A.

    Published 2016
    “…In addition, using the GTL and G50 fuels as alternatives to the diesel resulted in a significant decrease in engine CO, NOx, and SO2 emissions. 2016 Faculty of Engineering, Alexandria University…”
    Get full text
    Get full text
  17. 19037
  18. 19038
  19. 19039
  20. 19040